Dissertation/Thesis Abstract

Characterization and optimization of nanoparticles for polynucleotide delivery
by Conjeevaram Nagarajan, Bhavani Saranya, M.S., University of North Texas Health Science Center at Fort Worth, 2015, 78; 1595763
Abstract (Summary)

Nucleic acid therapeutics involves the use of polynucleotides (DNA, RNA) as novel therapeutic agents for the treatment of a wide range of diseases including cancer and several metabolic and genetic disorders. However, the highly unstable nature of RNA molecules necessitates the use of drug carriers to prevent them from nuclease degradation and facilitate targeted delivery in vivo. Hence, this study was conducted to optimize the preparation of nanoparticle carriers in order to improve the entrapment of the polynucleotides (siRNA and mRNA). Additionally, as heterogeneity and stability of nanoparticle formulations are major issues preventing the clinical approval of therapeutic formulations this study was also focused on improving the homogeneity and the stability of the nanoparticles.

In the siRNA study, reconstituted high density lipoprotein (rHDL) nanoparticles were used as the delivery vector. Optimization of siRNA-rHDL formulation was attempted with respect to homogeneity, size of the nanoparticle and entrapment efficiency of siRNA. The size analysis(DLS) showed that the inclusion of the lyophilization step in the preparation of nanoparticles resulted in a marginal increase in the homogeneity. Additionally, a modification of the protocol which involved the incubation of the phospholipid (EYPC) and the detergent (sodium cholate) mix a 37 °C for 2 hours also improved the homogeneity of the nanoparticles. The size analysis of siRNA rHDL nanoparticles using AFM and TEM imaging revealed the presence of spherical nanoparticles in the range of 10-16nm. Optimization studies with mRNA peptide nanoparticle formulation were conducted using a combination of cationic detergents and peptides at varied concentrations. The particle size analysis via Dynamic Light Scattering (DLS) detector revealed the presence of 268 nm diameter particles as the major component of the mRNA nanoparticle formulation that involved the combination of DOTAP (neutralizer) and Myr-5A (Apo A-I mimetic peptide). Further optimization of this formulation will be required to improve the homogeneity of the nanoparticles.

Indexing (document details)
Advisor: Lacko, Andras G.
Commitee: Cistola, David P., Krishnamoorthy, Raghu, Mifflin, Steve
School: University of North Texas Health Science Center at Fort Worth
Department: Integrative Physiology
School Location: United States -- Texas
Source: MAI 55/01M(E), Masters Abstracts International
Source Type: DISSERTATION
Subjects: Biochemistry, Health sciences, Nanotechnology
Keywords: Genetic disorders, Nanoparticles, Nucleic acid therapeutics, mRNA, rHDL, siRNA
Publication Number: 1595763
ISBN: 9781321952636
Copyright © 2019 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest